TARC, human recombinant protein
C-C motif chemokine 17, Small-inducible cytokine A17, Thymus and activation-regulated chemokine, CC
|Calculated MW||8.0 kDa|
|Other Names||C-C motif chemokine 17, Small-inducible cytokine A17, Thymus and activation-regulated chemokine, CC chemokine TARC, ABCD-2, CCL17, CCL-17, SCYA17, TARC, A-152E5, 3, MGC138271, MGC138273,|
|Application Notes||Reconstitute in H₂O to a concentration of 0.1-1.0 mg/ml. This solution can then be diluted into other aqueous buffers|
|Storage||-20°C; Sterile filtered and lyophilized from a concentrated (0.5 mg/ml) solution containing 20 mM PBS & 150 mM NaCl pH7.4.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Human TARC is a recently discovered protein belonging to the β-chemokine (C-C) family of cytokines. It has been shown that TARC is chemotactic towards T-cells but ineffective on monocytes. The recombinant human TARC is an 8.0 kDa protein containing 71 amino acid residues.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.